Sacro-hysteropexy Using Proline Mesh Versus Mersilene Tape in Apical Prolapse
Launched by MOHAMED ELSIBAI ANTER · Jan 17, 2022
Trial Information
Current as of July 22, 2025
Completed
Keywords
ClinConnect Summary
Aim of this study is to compare between using poly-proline mesh versus mersilene tape in abdominal sacrohysteropexy repairing apical prolapse stage ӀӀ or more.
Study Design: This will be a prospective randomized controlled non blind study will include cases with apical prolapse stage 2 or more undergoing abdominal sling between October 2019 and September 2020 in Obstetrics and Gynecology Department, Ain Shams University Hospital and menofia university hospital.
Inclusion Criteria: Women planning sacrohysteropexy for stage 2, 3, or 4 prolapse with or without stress urinary incontinence, Ag...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women planning sacrohysteropexy for stage 2, 3, or 4 prolapse with or without stress urinary incontinence.
- • Age between 25 and 45
- • Patient has no uterine pathology necessitate hysterectomy and patient wish to retain her uterus.
- Exclusion Criteria:
- • Unfitness for anesthesia
- • Present pelvic inflammatory disease
- • Previously identified or suspected massive adhesions between sigmoid and pre-sacral peritoneum.
- • Previous pelvic operations or trial of sling operation
About Mohamed Elsibai Anter
Mohamed Elsibai Anter is a dedicated clinical trial sponsor with extensive expertise in the design and management of clinical research initiatives. Committed to advancing medical science, he focuses on innovative therapies and treatments across various therapeutic areas. His strategic approach emphasizes collaboration with research institutions and regulatory bodies to ensure compliance and ethical standards throughout the trial process. With a strong emphasis on patient safety and data integrity, Mohamed Elsibai Anter is devoted to contributing to the development of effective healthcare solutions that address unmet medical needs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shibīn Al Kawm, Menoufia, Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials